Istana Negara, through a Facebook post on its official page, said that these donations are part of the 80 million doses that have been promised by US President Joe Biden for developed and ...

On Monday the US began rolling out the Pfizer/BioNTech vaccine. The first vaccine to be approved in the US, it offers up to 95% protection against Covid-19. The first three million doses are being ...

The company said it would submit the information to the US Food and Drug Administration for potential expansion of the vaccine’s availability to people ages 18 to 59. Pfizer’s RSV vaccine ...

Pfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral ... to our business in future periods, helping us to further invest in activities that drive Pfizer’s ...

AFP previously debunked false claims that two-thirds of Pfizer vaccine recipients in Japan had died ten days after their jab.

GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the ...

Covid-19 jab rivals face off in court today as a weeks-long trial begins over an infringement on the life-saving vaccine technology's patent. Pharmaceutical giant Pfizer and drug manufacturer ...

Pfizer's one-time therapy ... up 2:42 PM UTC Worldcategory Bird flu outbreak in dairy cows fails to deter US raw milk sellers 5:08 PM UTC The Federal Communications Commission (FCC) said on ...

An RSV vaccine already used for older adults could help protect people as young as 18 who are at increased risk of the disease, drugmaker Pfizer said in a news release Tuesday. The company said it ...